Vitiligo: a focus on pathogenesis and its therapeutic implications

C Bergqvist, K Ezzedine - The Journal of dermatology, 2021‏ - Wiley Online Library
Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy

K Boniface, J Seneschal, M Picardo, A Taïeb - Clinical reviews in allergy & …, 2018‏ - Springer
Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new …

N van Geel, R Speeckaert, A Taïeb… - Journal of the …, 2023‏ - Wiley Online Library
Background The treatment of vitiligo can be challenging and depends on several factors
such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually …

Prevalence of vitiligo among adults in the United States

K Gandhi, K Ezzedine, KP Anastassopoulos… - JAMA …, 2022‏ - jamanetwork.com
Importance Vitiligo can have profound effects on patients and is often associated with other
autoimmune comorbid conditions. It is important to understand the current prevalence of …

[HTML][HTML] Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

FX Danlos, AL Voisin, V Dyevre, JM Michot… - European Journal of …, 2018‏ - Elsevier
Objective Patients with autoimmune or inflammatory disease (AID) are susceptible to
immune-related adverse events (irAEs) when treated with immune check-point inhibitors …

Characteristics and pathogenesis of Koebner phenomenon

X Zhang, L Lei, L Jiang, C Fu, J Huang… - Experimental …, 2023‏ - Wiley Online Library
The Koebner phenomenon, also known as isomorphic reaction, refers to the development of
secondary lesions with the same clinical manifestations and histopathological …

British Association of Dermatologists guidelines for the management of people with vitiligo 2021

V Eleftheriadou, R Atkar, J Batchelor… - British Journal of …, 2022‏ - academic.oup.com
British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …

Vitiligo: pathogenesis, clinical variants and treatment approaches

G Iannella, A Greco, D Didona, B Didona, G Granata… - Autoimmunity …, 2016‏ - Elsevier
Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown,
which usually occurs with asymptomatic whitish patch or macule. Although several …

How does vitamin D affect immune cells crosstalk in autoimmune diseases?

D Gallo, D Baci, N Kustrimovic, N Lanzo… - International Journal of …, 2023‏ - mdpi.com
Vitamin D is a secosteroid hormone that is highly involved in bone health. Mounting
evidence revealed that, in addition to the regulation of mineral metabolism, vitamin D is …

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial

K Ezzedine, E Peeva, Y Yamaguchi, LA Cox… - Journal of the American …, 2023‏ - Elsevier
Background Vitiligo is a chronic autoimmune disorder characterized by depigmented
patches of the skin. Objective To evaluate the efficacy and safety of ritlecitinib, an oral JAK3 …